Yposkesi breaks ground on second gene therapy plant in Genopole, France

Yposkesi, a French CMO owned by SK Inc., has begun construction of a second plant in Genopole, France, costing EUR 58 million. The facility will double production capacity and is expected to be completed by 2023.

“Yposkesi broke ground for its second factory that would cost 58 million euros ($70 million).”pulse.mk.co.kr

• 1 source
• pulse.mk.co.krFrench CMO Yposkesi owned by SK builds 2nd plant to extend capacity - 매일경제 영문뉴스 펄스(Pulse)Jun 15, 2021

Summarized from public sources; check the original articles before acting on it.